ES2511056T3 - Biomarcadores para esquizofrenia u otros trastornos psicóticos - Google Patents

Biomarcadores para esquizofrenia u otros trastornos psicóticos Download PDF

Info

Publication number
ES2511056T3
ES2511056T3 ES10755224.2T ES10755224T ES2511056T3 ES 2511056 T3 ES2511056 T3 ES 2511056T3 ES 10755224 T ES10755224 T ES 10755224T ES 2511056 T3 ES2511056 T3 ES 2511056T3
Authority
ES
Spain
Prior art keywords
schizophrenia
biomarkers
psychotic disorders
psychotic
disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES10755224.2T
Other languages
English (en)
Inventor
Sabine Bahn
Yishai Levin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cambridge Enterprise Ltd
Original Assignee
Cambridge Enterprise Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cambridge Enterprise Ltd filed Critical Cambridge Enterprise Ltd
Application granted granted Critical
Publication of ES2511056T3 publication Critical patent/ES2511056T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/30—Psychoses; Psychiatry
    • G01N2800/302—Schizophrenia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

El uso de Sinaptotagmina-10 como biomarcador para la esquizofrenia u otro trastorno psicótico, o la predisposición a ello.

Description

imagen1
imagen2
imagen3
imagen4
imagen5
imagen6
imagen7
imagen8
imagen9

Claims (1)

  1. imagen1
    imagen2
ES10755224.2T 2009-09-09 2010-09-09 Biomarcadores para esquizofrenia u otros trastornos psicóticos Active ES2511056T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0915736 2009-09-09
GBGB0915736.3A GB0915736D0 (en) 2009-09-09 2009-09-09 Biomarkers
PCT/GB2010/051509 WO2011030153A1 (en) 2009-09-09 2010-09-09 Biomarkers for schizophrenia or other psychotic disorders

Publications (1)

Publication Number Publication Date
ES2511056T3 true ES2511056T3 (es) 2014-10-22

Family

ID=41203419

Family Applications (1)

Application Number Title Priority Date Filing Date
ES10755224.2T Active ES2511056T3 (es) 2009-09-09 2010-09-09 Biomarcadores para esquizofrenia u otros trastornos psicóticos

Country Status (8)

Country Link
US (1) US20120251553A1 (es)
EP (2) EP2475997B1 (es)
CA (1) CA2773429A1 (es)
DK (1) DK2475997T3 (es)
ES (1) ES2511056T3 (es)
GB (1) GB0915736D0 (es)
PT (1) PT2475997E (es)
WO (1) WO2011030153A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201210565D0 (en) 2012-06-14 2012-08-01 Cambridge Entpr Ltd Biomarkers
JP6205175B2 (ja) 2013-05-16 2017-10-04 株式会社Ｒｅｓｖｏ 精神・神経疾患バイオマーカー
GB201404189D0 (en) * 2014-03-10 2014-04-23 Cambridge Entpr Ltd Novel biomarkers
KR102256859B1 (ko) * 2019-03-12 2021-05-27 건국대학교 산학협력단 알츠하이머병의 진단용 조성물
KR102078500B1 (ko) * 2019-03-12 2020-02-17 건국대학교 산학협력단 알츠하이머병의 진단용 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998040748A1 (en) * 1997-03-14 1998-09-17 Neuromark Diagnosing neurologic disorders
JP2004135667A (ja) 2002-09-27 2004-05-13 Japan Science & Technology Agency 血液を用いた統合失調症の診断方法
WO2005007090A2 (en) * 2003-07-03 2005-01-27 President And Fellows Of Harvard College Inhibitors of the map kinase pathway
US20090175827A1 (en) 2006-12-29 2009-07-09 Byrom Mike W miR-16 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION
GB0701626D0 (en) 2007-01-22 2007-03-07 Cambridge Entpr Ltd Methods and biomarkers for diagnosing and monitoring psychotic disorders
GB0724735D0 (en) 2007-12-19 2008-01-30 Psynova Neurotech Ltd Methods and biomarkers for diagnosing and monitoring psychotic disorders

Also Published As

Publication number Publication date
PT2475997E (pt) 2014-10-08
DK2475997T3 (da) 2014-10-13
GB0915736D0 (en) 2009-10-07
EP2475997B1 (en) 2014-07-02
US20120251553A1 (en) 2012-10-04
EP2475997A1 (en) 2012-07-18
EP2790021A1 (en) 2014-10-15
WO2011030153A1 (en) 2011-03-17
CA2773429A1 (en) 2011-03-17

Similar Documents

Publication Publication Date Title
ES2644844T3 (es) Mecanismo de soporte
ECSP12012317A (es) Marcadores predictivos útiles en el tratamiento del síndrome frágil x (fxs)
BRPI0817475A2 (pt) meio legível por computador.
UY4211Q (es) Pizarra para marcadores
UY34765A (es) Compuestos novedosos.
ES2511056T3 (es) Biomarcadores para esquizofrenia u otros trastornos psicóticos
TWD165999S (zh) 銷售點列印機
BR112014014279A8 (pt) método para obter dados úteis para o diagnóstico e/ou prognóstico de insuficiência renal aguda; uso de pelo menos um micro-rna; kit para o diagnóstico e/ou prognóstico de insuficiência renal aguda e uso do kit
ES2664171T3 (es) Aditivo retardador del fraguado y plastificante para el hormigón
ES2572368T3 (es) Tratamiento de la artrosis
DK2359142T3 (da) Importin 9 som biomarkør for skizofreni
CO7160087A2 (es) Nalmefeno para reducir el consumo de alcohol en poblaciones diana específicas
HN2009003469A (es) Biscocho lleno
BRPI0814897A2 (pt) Ímãs termicamente estabilizados para uso em fundo de poço.
EP2391653A4 (en) BIOMARKERS ASSOCIATED WITH NEPHROPATHY
BR112013005073A2 (pt) Processo para produção de 2-metil-1,4- naftoquinona
ES2644814T3 (es) Montaje de rodillo de alimentación
IT1397456B1 (it) Lampada per l'illuminazione di emergenza ad illuminamento uniforme.
ES2461016B1 (es) Método para el diagnóstico y/o pronóstico de obesidad mórbida
CH704790C1 (fr) Instrument d’écriture à pointe rétractable.
IT1396108B1 (it) Supporto asolato per la realizzazione di infissi dotati di alette spioventi.
ITAN20090037U1 (it) Supporto asolato per la realizzazione di infissi dotati di alette spioventi.
TWD156245S (zh) 按壓自動原子筆
TWD156243S (zh) 按壓自動原子筆
TR201010533U (tr) Hadde makinesi.